Estrella Immunopharma, Inc. ESLA
NASDAQ · United States · Health Technology
$0.4680-0.01 (-1.47%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.05 | -0.05 | 0.0% | $0 | — | -2.3%$0.74→$0.72 |
| Q1 2026 | 2026-05-18 | -0.05 | -0.19 | +73.7% | — | — | +2.7%$1.11→$1.14 |
| Q4 2025 | 2026-03-18 | -0.01 | -0.07 | +85.7% | — | — | -0.9%$1.11→$1.10 |
| Q3 2025 | 2025-11-12 | -0.13 | — | — | — | — | -12.4%$2.51→$2.20 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.